These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12110271)

  • 1. Damaging effects of advanced glycation end-products in the murine macrophage cell line J774A.1.
    Bassi AM; Ledda S; Valentini S; De Pascale MC; Rossi S; Odetti P; Cottalasso D
    Toxicol In Vitro; 2002 Aug; 16(4):339-47. PubMed ID: 12110271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant status in J774A.1 macrophage cell line during chronic exposure to glycated serum.
    Bassi AM; Ledda S; De Pascale MC; Penco S; Rossi S; Odetti P; Cottalasso D
    Biochem Cell Biol; 2005 Apr; 83(2):176-87. PubMed ID: 15864326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro.
    Luciano Viviani G; Puddu A; Sacchi G; Garuti A; Storace D; Durante A; Monacelli F; Odetti P
    Metabolism; 2008 Feb; 57(2):163-9. PubMed ID: 18191044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
    Miyazaki K; Nagai R; Horiuchi S
    J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELISA of pentosidine, an advanced glycation end product, in biological specimens.
    Taneda S; Monnier VM
    Clin Chem; 1994 Sep; 40(9):1766-73. PubMed ID: 8070089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
    Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-enzymic glycation of fibrous collagen: reaction products of glucose and ribose.
    Bailey AJ; Sims TJ; Avery NC; Halligan EP
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):385-90. PubMed ID: 7832750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of furosine and pentosidine in CAPD patients.
    Kumano K; Yokota S; Sakai T; Kobayashi N; Yoshida A; Yoshihara T; Shibata K; Izumi G; Wang H
    Adv Perit Dial; 1997; 13():53-7. PubMed ID: 9360651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal proximal tubular metabolism of protein-linked pentosidine, an advanced glycation end product.
    Asano M; Fujita Y; Ueda Y; Suzuki D; Miyata T; Sakai H; Saito A
    Nephron; 2002 Aug; 91(4):688-94. PubMed ID: 12138274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.
    Henle T; Deppisch R; Beck W; Hergesell O; Hänsch GM; Ritz E
    Nephrol Dial Transplant; 1999 Aug; 14(8):1968-75. PubMed ID: 10462279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early glycation products produce pentosidine cross-links on native proteins. novel mechanism of pentosidine formation and propagation of glycation.
    Chellan P; Nagaraj RH
    J Biol Chem; 2001 Feb; 276(6):3895-903. PubMed ID: 11076948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
    Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
    Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive and specific ELISA for plasma pentosidine.
    Izuhara Y; Miyata T; Ueda Y; Suzuki D; Asahi K; Inagi R; Sakai H; Kurokawa K
    Nephrol Dial Transplant; 1999 Mar; 14(3):576-80. PubMed ID: 10193802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal catabolism of advanced glycation end products: the fate of pentosidine.
    Miyata T; Ueda Y; Horie K; Nangaku M; Tanaka S; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 1998 Feb; 53(2):416-22. PubMed ID: 9461101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of advanced glycation end products in human cataractous lenses.
    Franke S; Dawczynski J; Strobel J; Niwa T; Stahl P; Stein G
    J Cataract Refract Surg; 2003 May; 29(5):998-1004. PubMed ID: 12781289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end-products in anterior chamber aqueous of cataractous patients.
    Franke S; Stein F; Dawczynski J; Blum M; Kubetschka U; Stein G; Strobel J
    J Cataract Refract Surg; 2003 Feb; 29(2):329-35. PubMed ID: 12648645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress".
    Izuhara Y; Miyata T; Saito K; Ishikawa N; Kakuta T; Nangaku M; Yoshida H; Saito A; Kurokawa K; van Ypersele de Strihou C
    Am J Kidney Dis; 2004 Jun; 43(6):1024-9. PubMed ID: 15168382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood.
    Tsukahara H; Ohta N; Sato S; Hiraoka M; Shukunami K; Uchiyama M; Kawakami H; Sekine K; Mayumi M
    Free Radic Res; 2004 Jul; 38(7):691-5. PubMed ID: 15453634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.